Aug 12, 2020
Liver Disease Diagnostics Market Size Worth $48.7 Billion By 2027: Grand View Research, Inc.
May 11, 2020
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs
Mar 16, 2020
Akero Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Feb 03, 2020
OncoSec's Visceral Lesion Applicator (VLA) Electroporation Device Demonstrates Targeted Entry and Deployment in Both Lung and Liver in Data Presented at the Society of Interventional Oncology Annual Meeting
Jan 29, 2020
Called a 1st in U.S.: Living liver donors generously swap, saving 2 recipients
Jan 28, 2020
Enzychem Lifesciences Appoints Dr. Michael Charlton To Its Scientific Advisory Board
Jan 22, 2020
Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients
Dec 17, 2019
Enhanced production technology enables InSphero to reduce pricing of 3D InSight(TM) Human Liver Microtissues for broader access to assay-ready spheroid technology
Dec 10, 2019
Liver Health Supplements Market Size Worth $948.61 Million by 2025: Grand View Research, Inc.
Nov 21, 2019
Enzychem Lifesciences Presents EC-18 NASH Development Update at The Liver Meeting 2019
Nov 21, 2019
Elysium Health(TM) Announces Clinical Trial to Explore the Effect of Basis(TM) on Liver Fat Accumulation in Healthy Adults with Fatty Liver (NAFL)
Nov 11, 2019
Echosens at VA’s National Veterans Small Business Engagement Meeting: Demonstrating FibroScan Benefits for Early Detection and Monitoring of Liver Disease
Nov 07, 2019
Hepatic Encephalopathy Epidemiology Report 2019: Total Prevalent Case in the 7MM were Approx 525,000 in 2017 - Forecast to 2028
Nov 05, 2019
Liver Cancer Diagnostic Market to be Driven by Rising Prevalence of Liver Cancer Owing to Unhealthy Eating & Drinking Habits Till 2025 | Million Insights
Oct 21, 2019
DURECT Announces DUR-928 Phase 2a Alcoholic Hepatitis Study Results Selected for Late-Breaking Oral Presentation at The Liver Meeting® 2019
Oct 16, 2019
Seventy Percent of Liver Cancer Cases in the US Could be Prevented
Oct 10, 2019
Data to be Presented at AASLD 2019 Shows HighTide Lead Compound Improves NASH in Two Animal Models
Oct 03, 2019
Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero's 3D InSight(TM) Human Liver Disease platform
Sep 11, 2019
Q Biomed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic
Aug 27, 2019
Ascletis Received IND Approval for its NASH Drug